Vitamin D Supplementation in France in patients with or at risk for osteoporosis: Recent data and new practices

[en] With intermittent vitamin D supplementation, serum 25-hydroxyvitamin D (25OHD)levels may remain stable only if the dosing interval is shorter than 3 months, the ideal perhaps being about 1 month. Recent data support moderate daily vitamin D doses instead of high intermittent doses, notably in elderly patients prone to falls. The level of evidence is low, however, with no head-to-head comparisons of clinical outcomes such as fractures and falls in groups given identical dosages daily versus intermittently. A challenge to daily vitamin D supplementation in France is the absence of a suitable pharmaceutical formulation. In addition, daily dosing carries a high risk of poor adherence. Until suitable vitamin D3 formulations such as tablets or soft capsules each containing 1000 or 1500 IU become available, we suggest intermittent supplementation according to 2011 GRIO guidelines. Among the available dosages, the lowest should be preferred, with the shortest possible interval, e.g., 50,000 IU monthly rather than 100,000 every two months. © 2019 Société française de rhumatologie

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

Souberbielle, Jean-Claude; Service d'explorations fonctionnelles, hôpital Necker-Enfants malades, AP–HP, Paris, 75015, France

Cormier, Catherine; Rheumatology unit, Cochin Hospital, 27, rue du Faubourg Saint-Jacques, Paris, 75014, France

Cavalier, Etienne ; Université de Liège - ULiège > Département de pharmacie > Chimie médicale

Breuil, Véronique; Université Côte D'Azur, Service de rhumatologie, CHU de Nice, BIAM- UMR E 4320 TIRO-MATOs, CEA/UNS, centre hospitalier universitaire Nice, Nice, 06000, France

Debiais, Françoise; Service de rhumatologie, CHU de Poitiers, Poitiers, 86021, France

Fardellone, Patrice; Service de rhumatologie, CHU de Amiens, hôpital Nord, place Victor Pauchet, Amiens cedex 1, 80054, France

Guggenbuhl, Pascal; Institut NUMECAN, Inserm U 1241, Inra U 1341, Service de rhumatologie, hôpital Sud, CHU, Université de Rennes 1, Rennes, 35000, France

Javier, Rose-Marie; Service de rhumatologie, hôpitaux universitaires de Strasbourg, hôpital de Hautepierre, 1 avenue Molière, Strasbourg, 67200, France

Legrand, Érick; Service de rhumatologie, CHU d'Angers, Angers, 49000, France

Lespessailles, Éric; Service de rhumatologie, CHR Orléans, EA 4708 I3MTO, Université d'Orléans, Orléans, 45067, France

More authors (4 more)

Language :

English

Title :

Vitamin D Supplementation in France in patients with or at risk for osteoporosis: Recent data and new practices

Publication date :

2019

Journal title :

Joint Bone Spine

ISSN :

1297-319X

eISSN :

1778-7254

Publisher :

Elsevier Masson SAS

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 13 February 2020

Statistics

Number of views

78 (3 by ULiège)

Number of downloads

5 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Benhamou, CL, Souberbielle, JC, Cortet, B, et al. La vitamine D chez l'adulte : recommandations du GRIO. Presse Med 40 (2011), 673–682.
Bischoff-Ferrari, H, Willett, W, Orav, E, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367 (2012), 40–49.
Bischoff-Ferrari, H, Dawson-Hughes, B, Staehelin, HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ, 339, 2009, b3692.
Carmel, A, Shieh, A, Bang, H, Blockman, R, The 25(OH)D level to maintain a favourable bisphosphonate response is & 33 ng/mL. Osteoporos Int 23 (2012), 2479–2487.
Souberbielle, JC, Body, JJ, Lappe, JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmunity Rev 9 (2010), 709–715.
Larsen, T, Mose, F, Bech, J, et al. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized placebo-controlled trial. Am J Hypertension, 2012.
Mason, C, Xiao, L, Imayama, I, et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 99 (2014), 1015–1025.
Holick, M, Binkley, N, Bischoff-Ferrari, H, et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96 (2011), 1911–1930.
Adams, J, Hewison, M, Update in vitamin D. J Clin Endocrinol Metab 95 (2010), 471–478.
Dawson-Hughes, B, Mithal, A, Bonjour, JP, et al. IOF position statements: vitamin D recommendations for older adults. Osteoporos Int 21 (2010), 1151–1154.
Hanley, D, Cranney, A, Jones, G, et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 182 (2010), E610–E618.
Ross, C, Manson, JE, Abrams, S, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96 (2011), 53–58.
Luxwolda, M, Kuiperst, R, Kema, I, et al. Traditionnally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Br J Nutrition 108 (2012), 1557–1561.
Hathcock, J, Shao, A, Vieth, R, et al. Risk assessment for vitamin D. Am J Clin Nutr 85 (2007), 6–18.
Eisman, J, When is a U-curve actually a J-curve? Is it really too much of a good thing?. J Clin Endocrinol Metab 98 (2013), 1863–1864.
Souberbielle, JC, Massart, C, Brailly-Tabard, S, et al. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study. Endocrine 53 (2016), 543–550.
Vernay, M, Sponga, M, Salanave, B, et al. Statut en vitamine D de la population adulte en France : l’étude nationale nutrition santé (ENNS, 2006-2007). BEH, 2012, 189–194.
Touvier, M, Deschasaux, M, Montourcy, M, et al. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab 99 (2014), 1196–1203.
Souberbielle, JC, Benhamou, CL, Cortet, B, et al. Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phospho-calcique : les bonnes indications pour un remboursement raisonné du dosage de vitamine D. Ann Biol Clin (Paris) 72 (2015), 385–389.
Tafaro, L, Nati, G, Leoni, E, et al. Adherence to anti-osteoporotic therapies: role and determinants of “spot therapy”. Osteoporos Int 24 (2013), 2319–2323.
Armas, LAG, Hollis, BW, Heaney, RP, Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89 (2004), 5387–5391.
Sanders, KM, Stuart, AL, Williamson, EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303 (2010), 1815–1822.
Smith, H, Anderson, F, Raphael, P, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women – A population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46 (2007), 1852–1857.
Välimäki, VV, Löyttyniemi, E, Pekkarinen, T, et al. How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study on comparison between 100,000 IU and 200,000 IU of oral D3 every 3 months in elderly women. Clin Endocrinol (Oxf) 84 (2016), 837–844.
Darling, AL, Hart, KH, Gibbs, MA, et al. Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption. Osteoporos Int 25 (2014), 933–941.
Ish-Shalom, S, Segal, E, Salganik, T, et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 93 (2008), 3430–3435.
Bischoff-Ferrari, H, Dawson-Hughes, B, Orav, E, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Int Med, 2016, 10.1001/jamainternmed.2015.7148.
Bischoff-Ferrari, H, Dawson-Hughes, B, Platz, A, et al. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture. Arch Int Med 170 (2010), 813–820.
Cummings, S, Kiel, DP, Black, DM, Vitamin D supplementation and increased risk of falling: a cautionary tale of vitamin D supplement retold. JAMA Intern Med 176 (2016), 171–172.
Choi, HS, Min, Y-K, Byun, DW, et al. Korean Society for Bone and Mineral research task force report: perspectives on intermittent high-dose vitamin D supplementation. J Bone Metab 24 (2017), 141–145.
Hollis, B, Wagner, C, The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98 (2013), 4619–4628.
Vieth, R, How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Res 29 (2009), 3675–3784.
Muir, S, Montero-Odasso, M, Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59 (2011), 2291–2300.
Martineau, A, Jolliffe, D, Hooper, R, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 2017, i6583, 10.1136/bmj.6583.
Autier, P, Gandini, S, Mullie, P, A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab 97 (2012), 2606–2613.